Kodiak Sciences (KOD)
(Delayed Data from NSDQ)
$3.01 USD
-0.14 (-4.44%)
Updated Jun 6, 2024 04:00 PM ET
After-Market: $3.01 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
D Value B Growth C Momentum C VGM
Brokerage Reports
0 items in cart
Kodiak Sciences Inc. [KOD]
Reports for Purchase
Showing records 81 - 100 ( 127 total )
Company: Kodiak Sciences Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Kodiak Sciences Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Kodiak Sciences Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Kodiak Sciences Inc.
Industry: Medical - Biomedical and Genetics
Company: Kodiak Sciences Inc.
Industry: Medical - Biomedical and Genetics
4Q20- Busy 2021 Will Set the Stage for Multiple Topline Readouts in 2022
Provider: Roth Capital Partners, Inc.
Analyst: JALLAH Z
Company: Kodiak Sciences Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Kodiak Sciences Inc.
Industry: Medical - Biomedical and Genetics
Data Update Keeps Us Bullish, but Moving to Neutral on Valuation - $155 PT.
Provider: Roth Capital Partners, Inc.
Analyst: JALLAH Z
Company: Kodiak Sciences Inc.
Industry: Medical - Biomedical and Genetics
Company: Kodiak Sciences Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Kodiak Sciences Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Kodiak Sciences Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Kodiak Sciences Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Kodiak Sciences Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Kodiak Sciences Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Kodiak Sciences Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Kodiak Sciences Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Kodiak Sciences Inc.
Industry: Medical - Biomedical and Genetics
Company: Kodiak Sciences Inc.
Industry: Medical - Biomedical and Genetics
3Q20 Update - KSI-301, a Game Changing Anti-VEGF. Increasing PT to $133.
Provider: Roth Capital Partners, Inc.
Analyst: JALLAH Z
Company: Kodiak Sciences Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Kodiak Sciences Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department